lucida ds glutathione Disease-related biomarkers as experimental endpoints
Description
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies
Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivation
doi: 10.1034/j.1600-0633.2002.290402.x
(2000) 279:L423427
